In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Medarex achieves milestone in Amgen agreement
Medarex and Lonza Sign Collaboration Agreement for the Supply of Antibody-Based Products
Medarex and Lonza Sign Collaboration Agreement for the Supply of Antibody-Based Products
Medarex and Compugen Announce Therapeutic Antibody Co-Development Agreement
Medarex and Compugen announce therapeutic antibody co-development agreement
Medarex and Avalon announce antibody deal
Medarex amends antibody development agreement with Schering
Medarex and Organon announce antibody development agreement
KYOWA HAKKO AND AMGEN ENTER LICENSING AGREEMENT FOR ANTI-CCR4 HUMANIZED MONOCLONAL ANTIBODY
Medarex Announces Extension of Broad Antibody Development Relationship with Centocor